Program targets reductions in surgical complications with INVOSTM Cerebral Oximetry Monitoring
60-75% of high risk cardiac surgery patients experience cerebral desaturation1
Learn MoreCABG patients experiencing prolonged desaturation have 3x greater risk for prolonged hospital stay >6 days1 costing up to $31,0002
Learn MoreCABG surgery patients who experience prolonged desaturation have higher rates of major organ morbidity and mortality* than patients without prolonged desaturation.3
Learn MoreSurgical complications associated with cerebral desaturation (such as Major Organ Morbidity and Mortality) by implementing the INVOSTM System in the Operating Room
1. Schoen J, Husemann L, Tiemeyer C, et al. Cognitive function after sevoflurane- vs propofol-based anaesthesia for on-pump cardiac surgery: a randomized controlled trial. Br J Anaesth. 2011;106 (6): 840–50.
2. Deschamps A, Lambert J, Couture P, et al. Reversal of decreases in cerebral saturation in high-risk cardiac surgery. J Cardiothorac Vasc Anesth. Available online 18 June 2013, ISSN 1053-0770.
3. AHRQ Brief, February, 2014. Available at hcup-us.ahrq.gov/reports/statbriefs/sb170-Operating-Room-Procedures-United-States-2011.pdf.
*Major Morbidity and Operative Mortality is a composite endpoint defined as having one or more of the following six complications: permanent stroke, reoperation for any reason, renal failure, prolonged ventilation > 24 hours, mediastinitis or death per STS version 2.81
** Adult Cardiac Surgery patients